Cargando…
Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another. For such optical changes to be accounted for in the design of plasmonic...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912538/ https://www.ncbi.nlm.nih.gov/pubmed/27316744 http://dx.doi.org/10.1186/s11671-016-1524-4 |
_version_ | 1782438275111190528 |
---|---|
author | Chen, Allen L. Jackson, Meredith A. Lin, Adam Y. Figueroa, Elizabeth R. Hu, Ying S. Evans, Emily R. Asthana, Vishwaratn Young, Joseph K. Drezek, Rebekah A. |
author_facet | Chen, Allen L. Jackson, Meredith A. Lin, Adam Y. Figueroa, Elizabeth R. Hu, Ying S. Evans, Emily R. Asthana, Vishwaratn Young, Joseph K. Drezek, Rebekah A. |
author_sort | Chen, Allen L. |
collection | PubMed |
description | When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another. For such optical changes to be accounted for in the design of plasmonic NPs for light-based biomedical applications, quantitative design relationships between designable factors and spectral shifts need to be established. Here we begin building such a framework by investigating how functionalization of gold NPs (AuNPs) with biocompatible poly(ethylene) glycol (PEG), and the serum conditions in which the NPs are introduced to cells impact the optical changes exhibited by NPs in a cellular context. Utilizing darkfield hyperspectral imaging, we find that PEGylation decreases the spectral shifting and spectral broadening experienced by 100 nm AuNPs following uptake by Sk-Br-3 cells, but up to a 33 ± 12 nm shift in the spectral peak wavelength can still occur. The serum protein-containing biological medium also modulates the spectral changes experienced by cell-exposed NPs through the formation of a protein corona on the surface of NPs that mediates NP interactions with cells: PEGylated AuNPs exposed to cells in serum-free conditions experience greater spectral shifts than in serum-containing environments. Moreover, increased concentrations of serum (10, 25, or 50 %) result in the formation of smaller intracellular NP clusters and correspondingly reduced spectral shifts after 5 and 10 h NP-cell exposure. However, after 24 h, NP cluster size and spectral shifts are comparable and become independent of serum concentration. By elucidating the impact of PEGylation and serum concentration on the spectral changes experienced by plasmonic NPs in cells, this study provides a foundation for the optical engineering of plasmonic NPs for use in biomedical environments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11671-016-1524-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4912538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-49125382016-07-06 Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions Chen, Allen L. Jackson, Meredith A. Lin, Adam Y. Figueroa, Elizabeth R. Hu, Ying S. Evans, Emily R. Asthana, Vishwaratn Young, Joseph K. Drezek, Rebekah A. Nanoscale Res Lett Nano Express When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another. For such optical changes to be accounted for in the design of plasmonic NPs for light-based biomedical applications, quantitative design relationships between designable factors and spectral shifts need to be established. Here we begin building such a framework by investigating how functionalization of gold NPs (AuNPs) with biocompatible poly(ethylene) glycol (PEG), and the serum conditions in which the NPs are introduced to cells impact the optical changes exhibited by NPs in a cellular context. Utilizing darkfield hyperspectral imaging, we find that PEGylation decreases the spectral shifting and spectral broadening experienced by 100 nm AuNPs following uptake by Sk-Br-3 cells, but up to a 33 ± 12 nm shift in the spectral peak wavelength can still occur. The serum protein-containing biological medium also modulates the spectral changes experienced by cell-exposed NPs through the formation of a protein corona on the surface of NPs that mediates NP interactions with cells: PEGylated AuNPs exposed to cells in serum-free conditions experience greater spectral shifts than in serum-containing environments. Moreover, increased concentrations of serum (10, 25, or 50 %) result in the formation of smaller intracellular NP clusters and correspondingly reduced spectral shifts after 5 and 10 h NP-cell exposure. However, after 24 h, NP cluster size and spectral shifts are comparable and become independent of serum concentration. By elucidating the impact of PEGylation and serum concentration on the spectral changes experienced by plasmonic NPs in cells, this study provides a foundation for the optical engineering of plasmonic NPs for use in biomedical environments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11671-016-1524-4) contains supplementary material, which is available to authorized users. Springer US 2016-06-18 /pmc/articles/PMC4912538/ /pubmed/27316744 http://dx.doi.org/10.1186/s11671-016-1524-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Nano Express Chen, Allen L. Jackson, Meredith A. Lin, Adam Y. Figueroa, Elizabeth R. Hu, Ying S. Evans, Emily R. Asthana, Vishwaratn Young, Joseph K. Drezek, Rebekah A. Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions |
title | Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions |
title_full | Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions |
title_fullStr | Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions |
title_full_unstemmed | Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions |
title_short | Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions |
title_sort | changes in optical properties of plasmonic nanoparticles in cellular environments are modulated by nanoparticle pegylation and serum conditions |
topic | Nano Express |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912538/ https://www.ncbi.nlm.nih.gov/pubmed/27316744 http://dx.doi.org/10.1186/s11671-016-1524-4 |
work_keys_str_mv | AT chenallenl changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT jacksonmereditha changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT linadamy changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT figueroaelizabethr changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT huyings changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT evansemilyr changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT asthanavishwaratn changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT youngjosephk changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions AT drezekrebekaha changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions |